期刊文献+

载肝素钠的鱼精蛋白-去氧胆酸纳米复合物的制备及其抗肿瘤活性 被引量:1

Preparation and Anti-tumor Activity of Protamine-deoxycholic Acid Nanocomplexes Loaded with Heparin Sodium
原文传递
导出
摘要 将鱼精蛋白与琥珀酰化去氧胆酸在交联剂作用下偶联,制备3种不同偶联度的鱼精蛋白-去氧胆酸偶联物(DP1~DP3)。选择偶联度为32%的DP3,通过静电作用与肝素钠形成稳定的纳米复合物。考察了DP3与肝素钠不同质量比下所得纳米复合物的粒径、ζ电位和载药能力。结果表明,DP3与肝素钠质量比为1.5∶1时,DP3包载肝素钠的能力趋于饱和。此时得到的纳米复合物粒径为(136.0±2.5)nm,多分散系数为0.164±0.005,ζ电位为(+32.6±0.1)m V。与游离肝素钠相比,该纳米复合物能有效提高肝素钠向人肺腺癌A549细胞内的传递效率,并对A549肿瘤细胞呈现较高的生长抑制作用,而DP3未见明显的细胞毒性。 The protamine-deoxycholic acid conjugates with different conjugation degrees (DP1 - DP3) were synthesized through the reaction between protamine and N-hydroxysuccinimide ester of deoxycholic acid. The DP3 with conjugation degree of 32% was used to prepare the stable nanocomplexes loaded with heparin sodium via electrostatic interaction. The particle size, ζ potential and drug loading capacity of the nanocomplexes with different feed weight ratios of DP3 to heparin sodium were investigated. The results showed that when the ratio of DP3 to heparin sodium was 1.5 : 1, the loading capacity was nearly saturated. Under this preparation condition, the particle size, polydispersity index and ζpotential of the nanocomplexes were (136.0±2.5) nm, 0.164±0.005 and (+32.6±0.1) mV, respectively. Compared with the free heparin sodium, the above complexes could effectively induce intracellular delivery of heparin sodium into human lung adenocarcinoma A549 cells. The cytotoxicity assay in vitro showed that the nanocomplexes had a strong growth inhibition effect on A549 cells while DP3 had no marked cytotoxicity.
出处 《中国医药工业杂志》 CAS CSCD 北大核心 2015年第11期1192-1196,1263,共6页 Chinese Journal of Pharmaceuticals
基金 国家自然科学基金青年基金(21306066) 江苏省自然科学基金青年基金(BK2012557)
关键词 鱼精蛋白 去氧胆酸 肝素 纳米复合物 制备 抗肿瘤活性 protamine deoxycholic acid heparin nanocomplex preparation anti-tumor activity
  • 相关文献

参考文献16

  • 1Knelson EH, Nee JC, Blobe GC.Heparan sulfate signaling incancer[J].Trends Biochem Sci, 2014, 39(6): 277-288. 被引量:1
  • 2Lever R, Page CP.Non-anticoagulant effects of heparin: anoverview[J].Handb Exp Pharmacol, 2012, (207): 281-305. 被引量:1
  • 3Yotsumoto F, Tokunaga E, Oki E, et al.Molecular hierarchyof heparin-binding EGF-like growth factor-regulatedangiogenesis in triple-negative breast cancer[J].Mol CancerRes, 2013, 11(5): 506-517. 被引量:1
  • 4Harris NC, Davydova N, Roufail S, et al.The propeptidesof VEGF-D de t e rmine hepa r in binding, r e c eptorheterodimerization, and effects on tumor biology[J].J BiolChem, 2013, 288(12): 8176-8186. 被引量:1
  • 5Bendas G, Borsig L.Cancer cell adhesion and metastasis:selectins, integrins, and the inhibitory potential of heparins[J].Int J Cell Biol, 2012, 2012: 676731. 被引量:1
  • 6Berry D, Lynn DM, Sasisekharan R, et al.Poly(beta-aminoester)s promote cellular uptake of heparin and cancer celldeath[J].Chem Biol, 2004, 11(4): 487-498. 被引量:1
  • 7Raman K, Mencio C, Desai UR, et al.Sulfation patternsdetermine cellular internalization of heparin-likepolysaccharides[J].Mol Pharm, 2013, 10(4): 1442-1449. 被引量:1
  • 8Delgado D, del Pozo-Rodríguez A, Solinís Má, et al.Understanding the mechanism of protamine in solid lipidnanoparticle-based lipofection: the importance of the entrypathway[J].Eur J Pharm Biopharm, 2011, 79(3): 495-502. 被引量:1
  • 9He H, Ye J, Liu E, et al.Low molecular weight protamine(LMWP): a nontoxic protamine substitute and an effectivecell-penetrating peptide[J].J Controlled Release, 2014, 193:63-73. 被引量:1
  • 10Erdem-Cakmak F, Ozbas-Turan S, Salva E, et al.Comparisonof VEGF gene silencing efficiencies of chitosan andprotamine complexes containing shRNA[J].Cell Biol Int,2014, 38(11): 1260-1270. 被引量:1

同被引文献27

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部